These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38907545)

  • 1. Risk of vitiligo in patients with SARS-CoV-2 vaccination or infection: a nationwide cohort study.
    Kim JS; Jeong CY; Lee GJ; Yeom SW; Nam KH
    Eur J Dermatol; 2024 Apr; 34(2):150-157. PubMed ID: 38907545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Influenza Vaccination With SARS-CoV-2 Infection and Associated Hospitalization and Mortality Among Patients Aged 66 Years or Older.
    Hosseini-Moghaddam SM; He S; Calzavara A; Campitelli MA; Kwong JC
    JAMA Netw Open; 2022 Sep; 5(9):e2233730. PubMed ID: 36169955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 vaccine effectiveness and clinical outcomes in hemodialysis patients: the NHIS-COVID-19 cohort study in South Korea.
    Lee YK; Jeong SA; Park HC; Kim DH; Yoo KD; Yoon HE; Kim YG; Cho A
    Front Public Health; 2024; 12():1372525. PubMed ID: 38784571
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoimmune adverse event following COVID-19 vaccination in Seoul, South Korea.
    Kim HJ; Kim MH; Park SJ; Choi MG; Chun EM
    J Allergy Clin Immunol; 2024 Jun; 153(6):1711-1720. PubMed ID: 38520423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 Vaccine-Associated Uveitis in Patients With a History of Uveitis.
    Kim J; Kwon HY; Ahn SJ
    JAMA Ophthalmol; 2024 Jun; 142(6):522-528. PubMed ID: 38662361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of COVID-19 Vaccination With Breakthrough Infections and Complications in Patients With Cancer.
    Gong IY; Vijenthira A; Powis M; Calzavara A; Patrikar A; Sutradhar R; Hicks LK; Wilton D; Singh S; Krzyzanowska MK; Cheung MC
    JAMA Oncol; 2023 Mar; 9(3):386-394. PubMed ID: 36580318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of diabetes following COVID-19 vaccination and SARS-CoV-2 infection in Hong Kong: A population-based cohort study.
    Xiong X; Lui DTW; Chung MSH; Au ICH; Lai FTT; Wan EYF; Chui CSL; Li X; Cheng FWT; Cheung CL; Chan EWY; Lee CH; Woo YC; Tan KCB; Wong CKH; Wong ICK
    PLoS Med; 2023 Jul; 20(7):e1004274. PubMed ID: 37486927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risks of alopecia areata in long COVID: Binational population-based cohort studies from South Korea and Japan.
    Kyung S; Son Y; Kim M; Kang J; Smith L; Lee H; Yon DK
    J Med Virol; 2024 May; 96(5):e29668. PubMed ID: 38757870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of adenotonsillar disease and adenotonsillectomy with the development of vitiligo: A nationwide population-based cohort study.
    Kim JS; Lee MG; Lee SK; Yeom SW; Kang MG; Lee JH; Lee IJ; Park J; Yun SK; Nam KH
    Front Med (Lausanne); 2022; 9():1004218. PubMed ID: 36405619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SARS-CoV-2 vaccination and myocarditis or myopericarditis: population based cohort study.
    Husby A; Hansen JV; Fosbøl E; Thiesson EM; Madsen M; Thomsen RW; Sørensen HT; Andersen M; Wohlfahrt J; Gislason G; Torp-Pedersen C; Køber L; Hviid A
    BMJ; 2021 Dec; 375():e068665. PubMed ID: 34916207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine effectiveness of the first dose of ChAdOx1 nCoV-19 and BNT162b2 against SARS-CoV-2 infection in residents of long-term care facilities in England (VIVALDI): a prospective cohort study.
    Shrotri M; Krutikov M; Palmer T; Giddings R; Azmi B; Subbarao S; Fuller C; Irwin-Singer A; Davies D; Tut G; Lopez Bernal J; Moss P; Hayward A; Copas A; Shallcross L
    Lancet Infect Dis; 2021 Nov; 21(11):1529-1538. PubMed ID: 34174193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association Between Immune Dysfunction and COVID-19 Breakthrough Infection After SARS-CoV-2 Vaccination in the US.
    Sun J; Zheng Q; Madhira V; Olex AL; Anzalone AJ; Vinson A; Singh JA; French E; Abraham AG; Mathew J; Safdar N; Agarwal G; Fitzgerald KC; Singh N; Topaloglu U; Chute CG; Mannon RB; Kirk GD; Patel RC;
    JAMA Intern Med; 2022 Feb; 182(2):153-162. PubMed ID: 34962505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial.
    Akova M; Unal S
    Trials; 2021 Apr; 22(1):276. PubMed ID: 33849629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Community risks for SARS-CoV-2 infection among fully vaccinated US adults by rurality: A retrospective cohort study from the National COVID Cohort Collaborative.
    Anzalone AJ; Sun J; Vinson AJ; Beasley WH; Hillegass WB; Murray K; Hendricks BM; Haendel M; Geary CR; Bailey KL; Hanson CK; Miele L; Horswell R; McMurry JA; Porterfield JZ; Vest MT; Bunnell HT; Harper JR; Price BS; Santangelo SL; Rosen CJ; McClay JC; Hodder SL;
    PLoS One; 2023; 18(1):e0279968. PubMed ID: 36603014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of cutaneous immune-related adverse events in long COVID: Multinational cohort studies in South Korea, Japan, and the UK.
    Kim H; Kyung S; Park J; Lee H; Lee M; Smith L; Rahmati M; Shin JY; Kang J; Jacob L; Papadopoulos NG; Rhee SY; Lee J; Kim HJ; Lee H; Yon DK
    J Med Virol; 2024 Jun; 96(6):e29740. PubMed ID: 38874226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A retrospective cohort study of incidence and risk factors for severe SARS-CoV-2 breakthrough infection among fully vaccinated people.
    Meister T; Kolde A; Fischer K; Pisarev H; Kolde R; Kalda R; Suija K; Tisler A; Uusküla A
    Sci Rep; 2023 May; 13(1):8531. PubMed ID: 37237050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased incidence of rheumatoid arthritis after COVID-19.
    Marín JS; Mazenett-Granados EA; Salazar-Uribe JC; Sarmiento M; Suárez JF; Rojas M; Munera M; Pérez R; Morales C; Dominguez JI; Anaya JM
    Autoimmun Rev; 2023 Oct; 22(10):103409. PubMed ID: 37597602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study.
    Antonelli M; Penfold RS; Merino J; Sudre CH; Molteni E; Berry S; Canas LS; Graham MS; Klaser K; Modat M; Murray B; Kerfoot E; Chen L; Deng J; Österdahl MF; Cheetham NJ; Drew DA; Nguyen LH; Pujol JC; Hu C; Selvachandran S; Polidori L; May A; Wolf J; Chan AT; Hammers A; Duncan EL; Spector TD; Ourselin S; Steves CJ
    Lancet Infect Dis; 2022 Jan; 22(1):43-55. PubMed ID: 34480857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care.
    Syed U; Subramanian A; Wraith DC; Lord JM; McGee K; Ghokale K; Nirantharakumar K; Haroon S
    BMC Med; 2023 Sep; 21(1):363. PubMed ID: 37735654
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative Effectiveness of COVID-19 Bivalent Versus Monovalent mRNA Vaccines in the Early Stage of Bivalent Vaccination in Korea: October 2022 to January 2023.
    Kim RK; Choe YJ; Jang EJ; Chae C; Hwang JH; Lee KH; Shim JA; Kwon GY; Lee JY; Park YJ; Lee SW; Kwon D
    J Korean Med Sci; 2023 Nov; 38(46):e396. PubMed ID: 38013649
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.